maklogo
Market Research Report

Global 3D Printed Brain Models Market Insights, Size, and Forecast By Application (Medical Training, Surgical Planning, Patient-Specific Models, Research and Development), By Material Used (Plastic, Bioprinting Materials, Metal, Ceramics), By End Use (Hospitals, Research Institutions, Educational Institutes), By Technology (Fused Deposition Modeling, Stereolithography, Selective Laser Sintering), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:29721
Published Date:Jan 2026
No. of Pages:205
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global 3D Printed Brain Models Market is projected to grow from USD 0.48 Billion in 2025 to USD 1.95 Billion by 2035, reflecting a compound annual growth rate of 16.4% from 2026 through 2035. This market encompasses the production of patient-specific or generalized anatomical replicas of the human brain using additive manufacturing technologies. These models find extensive use across various applications including surgical planning, medical education, research and development, and drug discovery. The primary drivers fueling market expansion include the increasing demand for personalized medicine, advancements in 3D printing technologies, and the rising prevalence of neurological disorders globally. Furthermore, the imperative for enhanced surgical precision and reduced procedural risks contributes significantly to the adoption of these models. However, the high initial investment associated with 3D printing equipment and materials, coupled with stringent regulatory frameworks for medical devices, poses notable restraints to market growth. Despite these challenges, the continuous innovation in biomaterials and printing techniques presents substantial opportunities for market players to develop more sophisticated and cost-effective solutions.

Global 3D Printed Brain Models Market Value (USD Billion) Analysis, 2025-2035

maklogo
16.4%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

The market's segmentation by application, material used, technology, and end use highlights its diverse landscape. The surgical planning segment currently holds the dominant share, underscoring the critical role 3D printed brain models play in preoperative visualization, rehearsal, and patient specific surgical approaches. These models enable surgeons to gain a deeper understanding of complex anatomies, thereby improving surgical outcomes and minimizing complications. The advancements in materials like photopolymers, thermoplastics, and hydrogels, along with printing technologies such as stereolithography, fused deposition modeling, and binder jetting, are continuously enhancing the fidelity and functionality of these brain models. The end-use segments, including hospitals, academic and research institutions, and pharmaceutical companies, are all demonstrating increased uptake, reflecting the broad utility of this technology across the healthcare ecosystem.

North America is currently the dominant region in the global 3D Printed Brain Models Market. This leadership is attributable to the robust healthcare infrastructure, high adoption rates of advanced medical technologies, significant research and development investments, and the presence of key market players and research institutions in the region. Conversely, Asia Pacific is poised to emerge as the fastest growing region during the forecast period. This rapid growth is driven by increasing healthcare expenditure, a rising awareness of advanced medical technologies, growing medical tourism, and a burgeoning patient pool coupled with improving economic conditions across countries in the region. Key players such as EOS, Stratasys, 3D Systems, EnvisionTEC, and Ultimaker are strategically focusing on mergers, acquisitions, partnerships, and product innovation to expand their market reach and strengthen their competitive positions. These strategies aim to leverage technological advancements and cater to the evolving demands of the global healthcare sector, particularly in emerging markets.

Quick Stats

  • Market Size (2025):

    USD 0.48 Billion

  • Projected Market Size (2035):

    USD 1.95 Billion

  • Leading Segment:

    Surgical Planning (42.5% Share)

  • Dominant Region (2025):

    North America (38.2% Share)

  • CAGR (2026-2035):

    16.4%

What is 3D Printed Brain Models?

3D printed brain models are physical replicas of human or animal brains, created layer by layer using additive manufacturing technology. These models can range from simplified anatomical representations to intricate, patient-specific duplicates derived from MRI or CT scans. They accurately reproduce the brain's complex structures, including gyri, sulci, and deeper regions, sometimes incorporating different material properties to mimic tissue variations. Their significance lies in providing tangible tools for medical education, allowing students and practitioners to explore neuroanatomy in a hands-on manner. In research, these models facilitate surgical planning, device prototyping for neurosurgery, and the study of brain pathologies, offering a valuable platform for visualization and experimentation without invasive procedures.

What are the Trends in Global 3D Printed Brain Models Market

  • AI Enhanced Bioprinting for Brain Models

  • Personalized Neurological Disease Modeling

  • Advanced Biomaterial Innovations for Neural Constructs

  • Miniaturized Organoids Revolutionizing Research

  • Therapeutic Drug Screening Platforms Expansion

AI Enhanced Bioprinting for Brain Models

AI enhanced bioprinting is revolutionizing the creation of intricate 3D brain models. This trend leverages artificial intelligence algorithms to optimize the bioprinting process, enabling unprecedented precision and complexity in replicated neural structures. AI analyzes imaging data and biological parameters, guiding robotic arms to deposit bioinks with meticulous accuracy. This allows for the fabrication of highly organized and functional brain tissues, mimicking the in vivo architecture more faithfully than traditional methods. The AI driven control extends to cell patterning, extracellular matrix deposition, and vascular network integration, all crucial for creating robust and realistic models. Consequently, researchers can develop sophisticated models for studying neurological diseases, drug screening, and understanding brain development, accelerating breakthroughs in neuroscience. This convergence of AI and bioprinting drastically improves the fidelity and utility of these vital research tools.

Personalized Neurological Disease Modeling

Personalized neurological disease modeling is a significant trend in the global 3D printed brain models market. Researchers and clinicians are increasingly leveraging 3D printing to create patient specific brain models that accurately replicate individual pathologies. These models are derived from patient imaging data allowing for the precise reproduction of unique anatomical features disease progression and even tumor characteristics. This personalization facilitates a deeper understanding of specific neurological conditions like Alzheimer's Parkinson's and various cancers at an individual level. It enables highly targeted drug testing surgical planning and therapy development within a patient's unique biological context leading to more effective and tailored treatments. The ability to model complex neurological diseases with such fidelity is transforming both research and clinical practice.

What are the Key Drivers Shaping the Global 3D Printed Brain Models Market

  • Advancements in Bioprinting Technology and Biomaterials

  • Rising Demand for Realistic Pre-clinical Brain Models

  • Increasing R&D Investments in Neuroscience and Neurological Disorders

  • Growing Adoption in Surgical Planning and Medical Training

  • Favorable Regulatory Landscape and Funding for Medical Innovation

Advancements in Bioprinting Technology and Biomaterials

Progress in bioprinting allows for more precise and complex fabrication of brain models. Innovations in biomaterials provide better bioinks, offering enhanced biocompatibility and mechanical properties that more accurately mimic real brain tissue. These advancements enable researchers to create models with improved cellular viability, vascular networks, and structural integrity. The ability to print diverse cell types and sophisticated architectures means more realistic and functional brain models can be developed. This directly fuels demand as researchers gain better tools for drug discovery, disease modeling, and understanding neurological conditions, thereby driving growth in the global 3D printed brain models market.

Rising Demand for Realistic Pre-clinical Brain Models

The growing need for realistic preclinical brain models is a significant driver in the global 3D printed brain models market. Researchers and pharmaceutical companies are increasingly seeking complex, high fidelity models that accurately mimic the intricate structures and functions of the human brain. Traditional animal models often fail to fully recapitulate human brain pathology, leading to limitations in drug discovery and disease understanding. 3D printed brain models offer superior anatomical and cellular precision, allowing for more relevant in vitro testing of neurological drugs, personalized medicine approaches, and a deeper understanding of neurodegenerative diseases like Alzheimer's and Parkinson's. This demand for improved biological relevance and predictive power fuels the adoption of advanced 3D printing technologies in neuroscience research.

Increasing R&D Investments in Neuroscience and Neurological Disorders

Increasing research and development investments in neuroscience and neurological disorders significantly propels the global 3D printed brain models market. As funding grows for understanding complex brain functions and diseases like Alzheimer's, Parkinson's, and epilepsy, there is a heightened demand for advanced, accurate research tools. 3D printed brain models offer unparalleled advantages for simulating brain anatomy, pathology, and drug interactions with high fidelity. These models enable researchers to conduct ethical, repeatable experiments, test novel therapies, and accelerate drug discovery without relying solely on animal models or human subjects for early stage investigations. This surge in neuroscience funding directly translates into greater adoption and innovation within the 3D printed brain models sector.

Global 3D Printed Brain Models Market Restraints

Ethical Concerns and Regulatory Hurdles in Brain Model Replication

Replicating human brain models presents substantial ethical dilemmas and regulatory hurdles. Developing these intricate models, especially those for drug testing or disease research, raises concerns about the potential for consciousness or sentience in artificial constructs. There are no clear guidelines on the ethical treatment of highly sophisticated brain models that might exhibit complex behaviors. Strict regulations are necessary to ensure responsible development and application, particularly regarding data privacy, informed consent for tissue donation, and the potential for misuse. Navigating these complex moral and legal landscapes requires international collaboration and consensus, slowing down research and market adoption due to the extensive time and resources needed to establish compliant frameworks. This creates significant delays and costs for manufacturers.

High Production Costs Limiting Widespread Adoption

High production costs significantly impede the widespread adoption of 3D printed brain models. The sophisticated materials required for accurate biological mimicry, such as biocompatible resins and advanced hydrogels, are inherently expensive. Furthermore, the specialized manufacturing processes, often involving high resolution multi material printing and post processing for sterility and functional validation, add substantial expense. These costs translate into high unit prices for the models, making them unaffordable for many research institutions, educational facilities, and small to medium sized pharmaceutical companies. Consequently, while the utility of these models for neuroscience research, surgical planning, and drug development is recognized, the prohibitive expenditure limits their accessibility to a smaller segment of well funded organizations, thereby restricting broader market penetration and slowing overall growth.

Global 3D Printed Brain Models Market Opportunities

Advancing Precision Medicine: Market for Patient-Specific 3D Printed Brain Models in Neurosurgery

The market for patient-specific 3D printed brain models offers a profound opportunity to advance precision medicine in neurosurgery. These highly accurate, anatomical replicas, derived from individual patient imaging data, empower surgeons to meticulously plan complex procedures. By providing a tangible, haptic model of a patient’s unique brain pathology, medical teams can precisely visualize tumor locations, vascular structures, and critical neural pathways before surgery.

This capability leads to significantly enhanced surgical precision, reduced operative time, and minimized risks to vital brain functions. Furthermore, these models are invaluable tools for resident training and patient education, fostering deeper understanding and trust. Simulating surgical approaches on a patient’s exact anatomy dramatically improves outcomes for intricate cases like tumor resections or aneurysm clipping. This personalized approach aligns with the global shift towards individualized healthcare, driving demand for innovative, patient-centric technologies within the rapidly evolving medical landscape. This niche segment offers substantial growth potential.

Accelerating Drug Discovery: Market for Advanced 3D Printed Brain Models for Neurological Research

The market for advanced 3D printed brain models presents a significant opportunity to revolutionize neurological drug discovery. These sophisticated models offer unprecedented realism, mimicking the complex architecture and cellular interactions of the human brain more accurately than traditional 2D cultures or animal models. This capability is vital for accelerating the identification of novel drug targets, screening potential therapeutics for efficacy and toxicity, and unraveling intricate disease mechanisms such as Alzheimers, Parkinsons, and stroke. Researchers and pharmaceutical companies globally are increasingly adopting these in vitro platforms to bridge the gap between preclinical studies and human trials, thereby reducing development time and costs. The demand is particularly strong in rapidly developing regions, where significant investments in biotechnology and healthcare infrastructure are driving scientific innovation. Providing more predictive and human relevant testing environments, these advanced models streamline the drug development pipeline, ultimately bringing life changing treatments to patients faster and more efficiently.

Global 3D Printed Brain Models Market Segmentation Analysis

Key Market Segments

By Application

  • •Medical Training
  • •Surgical Planning
  • •Patient-Specific Models
  • •Research and Development

By Material Used

  • •Plastic
  • •Bioprinting Materials
  • •Metal
  • •Ceramics

By Technology

  • •Fused Deposition Modeling
  • •Stereolithography
  • •Selective Laser Sintering

By End Use

  • •Hospitals
  • •Research Institutions
  • •Educational Institutes

Segment Share By Application

Share, By Application, 2025 (%)

  • Surgical Planning
  • Medical Training
  • Patient-Specific Models
  • Research and Development
maklogo
$0.48BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is Surgical Planning dominating the Global 3D Printed Brain Models Market?

Surgical Planning holds the largest share because these models provide neurosurgeons with unparalleled accuracy for intricate procedures. They enable detailed pre-operative visualization, allowing surgeons to rehearse complex operations, identify potential complications, and determine optimal surgical paths. This practice significantly reduces operative risks, shortens recovery times, and ultimately enhances patient safety and successful outcomes, making it an indispensable tool in modern neurosurgery.

What factors contribute to the significant adoption of 3D Printed Brain Models in Research and Development?

Research and Development is a key segment, leveraging these models for advanced neuroscientific studies, drug discovery, and disease pathology investigations. Researchers utilize 3D printed brains to simulate various neurological conditions, test new therapeutic approaches, and understand complex brain structures and functions in a controlled environment. This application accelerates innovation in neurology and neuroscience, driving continuous demand for increasingly sophisticated and accurate models.

How do different materials influence the utility of 3D Printed Brain Models?

The choice of material, such as plastic or bioprinting materials, dictates the model's application. While plastics are predominantly used for anatomical replicas in surgical planning and training due to their durability and cost-effectiveness, bioprinting materials are increasingly vital for creating living tissue models. These advanced models are crucial for simulating cellular functions, drug testing, and regenerative medicine research, expanding the market's scope beyond purely physical representations.

What Regulatory and Policy Factors Shape the Global 3D Printed Brain Models Market

The global regulatory landscape for 3D printed brain models is highly fragmented, reflecting diverse applications. Models used purely for academic research or educational purposes generally face minimal direct medical device oversight, often falling under general laboratory safety and quality guidelines. However, if intended for pre surgical planning, diagnostics, or patient specific treatment guidance, they are increasingly scrutinized as medical devices.

Key agencies like the US FDA, European Medicines Agency EMA, and national bodies are developing specific pathways for additive manufacturing products. These pathways often classify models based on risk, material biocompatibility, and intended use. Class II or III device classification may apply to patient specific models, necessitating robust validation, quality management systems such as ISO 13485, and extensive clinical evidence. Data privacy regulations, including GDPR and HIPAA, are critical for models derived from patient imaging data, requiring strict anonymization and consent protocols. Harmonization remains a challenge, yet a trend towards recognizing the diagnostic and therapeutic potential necessitates clearer, unified frameworks globally.

What New Technologies are Shaping Global 3D Printed Brain Models Market?

Innovations in 3D printed brain models are rapidly transforming neurological research and drug discovery. Advanced bioprinting techniques, leveraging sophisticated bioinks and patient specific cellular materials, enable the creation of highly biomimetic and functional brain tissue models. Emerging technologies focus on multi material printing, allowing the precise layering of diverse cell types and extracellular matrices to replicate complex brain structures and neural networks with unprecedented accuracy. The integration of microfluidics and organ on a chip platforms is crucial for developing dynamic, long term viable models that simulate physiological conditions and disease progression more effectively. Furthermore, AI driven design optimization and high resolution printing capabilities are enhancing the fidelity of these models, facilitating personalized medicine applications and accelerating therapeutic development for neurodegenerative diseases, stroke, and brain injuries. These advancements are propelling significant market expansion, driven by their potential to reduce animal testing and provide superior preclinical insights.

Global 3D Printed Brain Models Market Regional Analysis

Global 3D Printed Brain Models Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
38.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 38.2% share

North America leads the Global 3D Printed Brain Models Market with a substantial 38.2% share. This dominance stems from its robust healthcare infrastructure and extensive research and development initiatives. The region benefits from significant investments in advanced medical technologies and strong academic industry collaborations. Prominent universities and research institutions actively drive innovation in neurodegenerative disease modeling and drug discovery. Furthermore, a high adoption rate of sophisticated simulation tools and personalized medicine approaches contributes to its market leadership. Favorable government funding and a strong intellectual property landscape further solidify North America's position as the primary growth engine for this specialized market.

Fastest Growing Region

Asia Pacific · 18.2% CAGR

The Asia Pacific region is poised to be the fastest growing region in the Global 3D Printed Brain Models Market, projected to exhibit an impressive CAGR of 18.2% during the forecast period of 2026 to 2035. This accelerated growth is primarily fueled by a burgeoning healthcare infrastructure, increased research and development initiatives, and a rising prevalence of neurological disorders across key economies like China, India, and Japan. Governments in these nations are actively investing in advanced medical technologies and promoting innovative diagnostic and research tools. Furthermore, a growing awareness regarding the benefits of personalized medicine and the adoption of cutting edge simulation models for surgical planning and drug discovery are significant drivers. The accessibility of sophisticated 3D printing technologies coupled with a skilled scientific workforce further underpins this rapid expansion.

Top Countries Overview

The U.S. leads the global 3D printed brain models market, driven by advanced research institutions, robust funding, and pioneering biotech companies. High demand from academia and pharmaceutical sectors for neurological disease research, surgical planning, and drug discovery fuels market growth. Technological advancements in biomaterials and printing precision further solidify its dominant position in this innovative sector.

China is a crucial and growing player in the global 3D printed brain models market. Its strong manufacturing base, increasing R&D investments, and large patient population are driving significant advancements. Government support and a burgeoning biomedical industry further boost domestic production and adoption of these sophisticated models for neurological research and drug development, positioning China for substantial market expansion and technological innovation.

India is a significant emerging player in the global 3D printed brain models market. Its growing biomedical research, increasing prevalence of neurological disorders, and skilled workforce are driving market expansion. While currently smaller than Western counterparts, domestic manufacturing capabilities and government initiatives promoting medical technology adoption position India for substantial future growth in this niche.

Impact of Geopolitical and Macroeconomic Factors

Geopolitically, the market for 3D printed brain models is influenced by varying regulatory frameworks and ethical considerations across nations. Countries prioritizing biomedical research and technological advancement often foster innovation through supportive policies and funding for academic institutions and biotech companies. Conversely, regions with stricter bioethics laws or limited infrastructure for advanced manufacturing might see slower adoption, impacting market penetration. International collaborations in neuroscience and medical education can drive demand, but intellectual property disputes and data sharing regulations could pose challenges. Geopolitical tensions affecting global supply chains for specialized materials and printers also introduce significant risks and potential market disruptions.

Macroeconomically, healthcare spending trends and technological investment cycles are key drivers. Increased public and private investment in personalized medicine, neurological research, and medical training boosts demand for high fidelity anatomical models. Economic downturns, however, could lead to reduced research budgets and slower adoption rates in hospitals and universities. Inflationary pressures affecting raw material costs and manufacturing expenses will impact product pricing and profitability. Furthermore, the availability of skilled labor in biomechanical engineering and 3D printing across different economic zones will influence production capacity and market growth. Access to venture capital and grants for innovative medical technologies also plays a crucial role.

Recent Developments

  • March 2025

    Stratasys announced a strategic partnership with a leading neuroimaging research institute to co-develop advanced biomimetic materials specifically engineered for high-resolution 3D printed brain models. This collaboration aims to enhance the anatomical accuracy and functional simulation capabilities of their existing brain model offerings, paving the way for more realistic surgical planning and neurological disease research.

  • April 2025

    3D Systems unveiled its new 'NeuPrint Pro' system, a dedicated multi-material 3D printer designed for the precise creation of patient-specific brain models with integrated vascular networks. This product launch addresses the growing demand for highly detailed models that can accurately replicate complex cerebral structures, aiding in pre-surgical planning and medical device testing.

  • May 2025

    EOS acquired a specialized biomedical software company focused on converting MRI and CT scan data into printable 3D models with advanced tissue differentiation algorithms. This acquisition strengthens EOS's position in the personalized medicine sector, allowing them to offer a more comprehensive solution for medical professionals creating patient-specific brain models.

  • February 2025

    Ultimaker partnered with several academic medical centers across Europe to launch a new open-source research initiative focused on developing standardized protocols for 3D printing brain models for educational and training purposes. This strategic initiative aims to democratize access to advanced brain model creation, fostering broader adoption in medical schools and residency programs.

  • June 2025

    Carbon announced a new material breakthrough, introducing a bio-compatible, dissolvable resin specifically designed for 3D printed brain models that can be used in drug delivery studies. This innovative material allows researchers to simulate targeted drug release within brain tissue, offering new avenues for neurological drug development and testing.

Key Players Analysis

The Global 3D Printed Brain Models Market is shaped by key players like EOS, Stratasys, and 3D Systems, who leverage advanced additive manufacturing technologies such as SLA, FDM, and PolyJet to create highly realistic models for medical research and surgical planning. Ultimaker and EnvisionTEC also contribute with specialized material extrusion and DLP systems. Companies like Carbon focus on speed and material properties for more functional models, while Materialise and Fathom provide crucial software and service expertise. GE Additive and Xometry represent broader industrial application and on demand manufacturing, respectively. Strategic initiatives include partnerships with research institutions and healthcare providers, driving market growth through improved surgical outcomes, reduced animal testing, and accelerated neurological research.

List of Key Companies:

  1. EOS
  2. Stratasys
  3. 3D Systems
  4. EnvisionTEC
  5. Ultimaker
  6. Fathom
  7. Carbon
  8. Materialise
  9. Xometry
  10. GE Additive
  11. Additive Industries
  12. Voxeljet
  13. Formlabs
  14. Sculpteo
  15. Shapeways
  16. HP

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 0.48 Billion
Forecast Value (2035)USD 1.95 Billion
CAGR (2026-2035)16.4%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Application:
    • •Medical Training
    • •Surgical Planning
    • •Patient-Specific Models
    • •Research and Development
  • By Material Used:
    • •Plastic
    • •Bioprinting Materials
    • •Metal
    • •Ceramics
  • By Technology:
    • •Fused Deposition Modeling
    • •Stereolithography
    • •Selective Laser Sintering
  • By End Use:
    • •Hospitals
    • •Research Institutions
    • •Educational Institutes
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global 3D Printed Brain Models Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.1.1. Medical Training
5.1.2. Surgical Planning
5.1.3. Patient-Specific Models
5.1.4. Research and Development
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Used
5.2.1. Plastic
5.2.2. Bioprinting Materials
5.2.3. Metal
5.2.4. Ceramics
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Technology
5.3.1. Fused Deposition Modeling
5.3.2. Stereolithography
5.3.3. Selective Laser Sintering
5.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
5.4.1. Hospitals
5.4.2. Research Institutions
5.4.3. Educational Institutes
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America 3D Printed Brain Models Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.1.1. Medical Training
6.1.2. Surgical Planning
6.1.3. Patient-Specific Models
6.1.4. Research and Development
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Used
6.2.1. Plastic
6.2.2. Bioprinting Materials
6.2.3. Metal
6.2.4. Ceramics
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Technology
6.3.1. Fused Deposition Modeling
6.3.2. Stereolithography
6.3.3. Selective Laser Sintering
6.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
6.4.1. Hospitals
6.4.2. Research Institutions
6.4.3. Educational Institutes
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe 3D Printed Brain Models Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.1.1. Medical Training
7.1.2. Surgical Planning
7.1.3. Patient-Specific Models
7.1.4. Research and Development
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Used
7.2.1. Plastic
7.2.2. Bioprinting Materials
7.2.3. Metal
7.2.4. Ceramics
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Technology
7.3.1. Fused Deposition Modeling
7.3.2. Stereolithography
7.3.3. Selective Laser Sintering
7.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
7.4.1. Hospitals
7.4.2. Research Institutions
7.4.3. Educational Institutes
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific 3D Printed Brain Models Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.1.1. Medical Training
8.1.2. Surgical Planning
8.1.3. Patient-Specific Models
8.1.4. Research and Development
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Used
8.2.1. Plastic
8.2.2. Bioprinting Materials
8.2.3. Metal
8.2.4. Ceramics
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Technology
8.3.1. Fused Deposition Modeling
8.3.2. Stereolithography
8.3.3. Selective Laser Sintering
8.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
8.4.1. Hospitals
8.4.2. Research Institutions
8.4.3. Educational Institutes
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America 3D Printed Brain Models Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.1.1. Medical Training
9.1.2. Surgical Planning
9.1.3. Patient-Specific Models
9.1.4. Research and Development
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Used
9.2.1. Plastic
9.2.2. Bioprinting Materials
9.2.3. Metal
9.2.4. Ceramics
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Technology
9.3.1. Fused Deposition Modeling
9.3.2. Stereolithography
9.3.3. Selective Laser Sintering
9.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
9.4.1. Hospitals
9.4.2. Research Institutions
9.4.3. Educational Institutes
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa 3D Printed Brain Models Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.1.1. Medical Training
10.1.2. Surgical Planning
10.1.3. Patient-Specific Models
10.1.4. Research and Development
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Used
10.2.1. Plastic
10.2.2. Bioprinting Materials
10.2.3. Metal
10.2.4. Ceramics
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Technology
10.3.1. Fused Deposition Modeling
10.3.2. Stereolithography
10.3.3. Selective Laser Sintering
10.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
10.4.1. Hospitals
10.4.2. Research Institutions
10.4.3. Educational Institutes
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. EOS
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Stratasys
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. 3D Systems
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. EnvisionTEC
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Ultimaker
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Fathom
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Carbon
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Materialise
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Xometry
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. GE Additive
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Additive Industries
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Voxeljet
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Formlabs
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Sculpteo
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. Shapeways
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis
11.2.16. HP
11.2.16.1. Business Overview
11.2.16.2. Products Offering
11.2.16.3. Financial Insights (Based on Availability)
11.2.16.4. Company Market Share Analysis
11.2.16.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.16.6. Strategy
11.2.16.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 2: Global 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Material Used, 2020-2035

Table 3: Global 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 4: Global 3D Printed Brain Models Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 5: Global 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 7: North America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Material Used, 2020-2035

Table 8: North America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 9: North America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 10: North America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 12: Europe 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Material Used, 2020-2035

Table 13: Europe 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 14: Europe 3D Printed Brain Models Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 15: Europe 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 17: Asia Pacific 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Material Used, 2020-2035

Table 18: Asia Pacific 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 19: Asia Pacific 3D Printed Brain Models Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 20: Asia Pacific 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 22: Latin America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Material Used, 2020-2035

Table 23: Latin America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 24: Latin America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 25: Latin America 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 27: Middle East & Africa 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Material Used, 2020-2035

Table 28: Middle East & Africa 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 29: Middle East & Africa 3D Printed Brain Models Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 30: Middle East & Africa 3D Printed Brain Models Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Packaging Transport Market Research

Explore comprehensive market research reports covering all aspects of the Packaging Transport industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;